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The book edited by Gerry Melino and David Vaux functions as
a compendium of cell death research, a journey that takes us
backtotheorigins,whileatthesametimeoffersaglimpseinto
the future of research in this area. Cell demise is a crucial
‘event’ in the regulation of development, tissue homeostasis
andimmuneresponse.Dysregulationofcell deathisknownto
contribute to human diseases, from cancer to autoimmune
disorders. Although this book provides a useful source for
experts in the ﬁeld, it will also serve as a textbook for students
at the undergraduate or postgraduate level who wish to
explore the dynamics and regulation of cell death, from
Caenorhabditis elegans to humans. As often the case with
review books of this nature, there is a certain degree of
repetition between chapters. This could have been avoided if
the book was structured to follow a more deﬁned line of
thought. Nevertheless, each chapter contains novel informa-
tion ensuring that this book stands out among the numerous
others centred on cell death and constitutes an extremely
useful addition.
The Philosophy of (Cell) Death
The ﬁrst chapter serves as an introduction to not just the
history of the study of cell death but also to the philosophy of
studying cell death. Appropriately, the stage is set with the
question of suicide proffered by the existential writer Camus
and the over-arching theme of the Siren’s Song from Homer’s
Odyssey (Figure 1). Even for those of a less philosophical
bent, this chapter provides a thorough history of the study of
cell death and serves as a reminder to even the most ardent
student that cell death was recognised in the nineteenth
century and that morphology was well described in the 1950s
and 1960s. Besides the subsequent recent history of a more
mechanistic elucidation of cell death, the authors also discuss
cell death from an evolutionary angle and consider the
therapeutic implications of many decades of research in
this area.
All in all, an effective and illuminating introduction that leads
to an interesting chapter is written by Jean-Claude Ameisen.
This is a thematic continuation of the ﬁrst one in that it
discusses the origin and evolution of programmed cell death.
Besides being a primer on cell death in evolutionary older
‘simpler’ organisms, this chapter also asks the central
question of when and why cell death arose and why this
questionisnotjustafunctionof‘complexity’.UsingC.elegans
as a model but not forgetting unicellular organisms and higher
animals, the author comes to the conclusion that the
molecular effectors of most essential functions, such as
metabolism, differentiation, cell cycle, etc., will induce cell
death if not regulated properly, whether for self-organisation
of the tissue in mammals or for host–pathogen interactions in
bacteria. Quite strikingly, Ameisen refers to this as the
‘Original Sin’ hypothesis, that the cell’s ability to commit
suicideisadirectconsequenceofitscapacitytoself-organise,
ﬂourish and reproduce. Perhaps a little anthropocentric but
nevertheless, food for thought!
Mechanisms: from C. elegans to Mammals
The following chapter comes from another leading scientist in
the ﬁeld of C. elegans, Michael Hengartner. In particular, the
authors propose the idea that cell death is a ‘terminal’ cell fate
during development. An interesting question raised by the
authors is why blocking death results in a ﬁxed number of
undead cells, although its activation does not have equally
‘precise’ effects.Germlinecelldeathisnicelywritten andclear
to non-experts, whereas the idea of oocytes acting as nurse
cells is very intriguing and requires further validation. It
remains to beestablishedwhether cell death inthe C. elegans
germ line is a stochastic phenomenon or whether nurse cells
are indeed more prone to cell death than fully functional
oocytes.
Mechanisms: Digestion by Caspases
The book then moves on to analysing the execution phase
of cell death, and in particular focuses on the involvement
of caspases. The chapter by Nicholson et al. provides an
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summary of the structure and active sites of caspases is
provided, detailing how these domains interact with each
other or with their adaptors and more than 1000 substrates.
Clear diagrams are used to introduce the three classes of
caspases on the basis of their function and structure. The
importantfeaturesofregulatoryandexecutionercaspases,as
well as their role in regulating the different stages of apoptosis
are described. This chapter then goes on to show how
understanding of the molecular mechanisms of catalysis and
identiﬁcation of functional domains of caspases, as well
as their effectors and inhibitors, has led to the development
of pharmacological caspase inhibitors. As highlighted and
discussed by the authors, the therapeutic outlook of a new
class of low-molecular-weight non-peptide caspase inhibitors
is promising for the development of future therapeutics, but
issues with efﬁcacy and toxicity need to be resolved.
Upstream to caspase activation lies the apoptosome, the
subject of the chapter by Cecconi and Ferraro. A detailed
description of the structure of Apaf1, Cyt c and caspase 9
illustrates the complex conformational changes resulting from
various interactions of the domains or modiﬁcations of Cyt c
that are necessary for the formation of an active apoptosome.
Importantly, the review describes the different levels of Apaf1
regulation by transcriptional regulation, gene hypermethyla-
tion or interaction with other cellular proteins. Rightly so, this
chapter also underlines the importance of the apoptosome
not only in cancer but also in neurodegenerative and human
congenital brain malformations, stressing the biomedical
importance of this complex.
Two chapters, by Walsh/Martin and Deming/Kornbluth, are
well written and raise a number of interesting questions.
However, both of these chapters recapitulate many of the
aspects of caspase classiﬁcation, function and regulation that
have been extensively discussed already in the previous
two chapters. Nonetheless, they both add further clariﬁcation
to different aspects of the execution phase of apoptosis. In
particular, Walsh and Martin discuss the role of caspases
in controlling the clearance of apoptotic debris, whereas
DemingandKornbluthdrawﬁvesimpleillustrationsexplaining
the processes leading to the dismantling of the cell during
programmed cell death.
Mechanisms: Intrinsically Mitochondria
As mentioned above, the main drawback of this book is the
lack of a clear rational ordering of the different chapters, as
chapters on the execution phase somewhat counter intuitively
precede those dedicated to the initiation phase. A ‘grande
presentation’ is given by David Vaux on the role of BCL2
family in cell-death regulation. This chapter is very useful for
anyone approaching this subject. A subclass of BCL2 family
members, the BH3-only proteins are key regulators of the
initiation phase of cell death. This is the subject of a well-
written chapter by Strasser et al., which provides useful
insights into the role of the individual BH3 family members in
the initiation of appropriate cell type and stimulus-speciﬁc
apoptosis. The exact mechanism of how BH3-only proteins
activate the pro-apoptotic members of the family such as
Bax/Bak to unleash the effector phases of apoptosis is
currently unclear. It is therefore particularly helpful to be
provided with clear explanation of the competing models of
either direct or indirect interaction of BH3-only proteins with
Bax,BakandBcl-2. Thischapterreviewsnewinsightsintothe
regulatory pathways controlling their expression and function,
such as microRNA-mediated control. Finally, it discusses the
involvement of BH3-only proteins in cancer and the develop-
ment of the BH3-mimetic drugs, providing a very useful table
on current and ongoing clinical trials with two such small
molecule BH3-mimetics, ABT-263 and its close relatives.
Most BCL2 family members display either a constitutive or
transient association with the mitochondria. These organelles
have a crucial role in the transduction of apoptotic signals
through the intrinsic pathway and work as gatekeepers of cell
demise. Parsons and Green, two leading researchers in this
ﬁeld, describe the deﬁning feature of the intrinsic pathway,
that is, the mitochondrial outer membrane permeabilisation
(MOMP). Importantly, the authors also explain how the non-
apoptotic function of the mitochondria, that of generating
energy for the cell (bioenergetics) is central to MOMP and
subsequent cell death. This is consistent with Ameisen’s
hypothesis in Chapter 2. Furthermore, it is not only factors
extrinsic to the mitochondria but the organelle’s inner work-
ings that regulate MOMP and cell death. These checkpoints
function in concert to control the mitochondrion’s and thus the
cell’s proper function. The mitochondria do not exist as single
entities but rather form long chains of fused organelles. These
chains undergo rounds of fusion/ﬁssion events, which have
been proposed to have a role during programmed cell death.
A chapter by Benard et al. on this subject clearly outlines the
regulation of mitochondrial network dynamics in cellular
physiology, and its key role in cell death. Addition of a few
important references should be helpful to the readers,
including the role of OPA1 in cristae remodelling (Scorrano’s
group) and the link between fusion and neurodegeneration
(Chan’s group).
Mechanisms: Death Threats from the Outside
Programmed cell death can be induced through the extrinsic
pathway, which has an important role in the immune system.
Death receptors (DRs) are central in this context. Krammer
and Lavrik’s short review on DRs is a short article that
highlights signalling through the different DRs and their
corresponding ligands. Discussion of DISC formation and
downstream regulation of caspase activity illuminates the
differences between various DR pathways. This chapter is
complex and lacks a conclusions/perspective section and a
number of important studies are not discussed, such as those
onTWEAK and its receptor Fn14 are missing. The potential of
therapeutic agents targeting DRs in cancer cells is discussed
in the following chapter by MacFarlane, which focuses
on TNF-related apoptosis-inducing ligand (TRAIL) and its
receptors TRAIL-R1 and TRAIL-R2. Understanding of the
structure and molecular mechanisms of these proteins has
already led to the development of therapeutic compounds.
The determination of the structure of TRAIL and TRAIL-R has
clearly aided the development of TRAIL-targeted thera-
peutics, several of which are currently in phase I and II clinical
trials. Further knowledge into the mechanisms underpinning
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development of further improved TRAIL-based anticancer
drugs.
DRs induce not only apoptosis but also other forms of cell
death, such as necroptosis. This is reviewed in the chapter by
Declercq and colleagues, who are experts in this ﬁeld. In
contrast to necrosis, this type of cellular demise is not
accidental and is dependent crucially on whether caspases
are active or not. DR-induced necroptosis signalling com-
plexes and necroptosis stimuli are nicely illustrated in a ﬁgure
andatable. Thephysiological roleof necroptosis inconditions
such as neurodegenerative diseases and viral infection
highlights the importance of this type of cell death in the
whole animal and the value of targeting this pathway for
therapeutic purposes.
How to Escape Death
In addition to BCL2-family members, apoptosis can be
inhibited by BIR domain-containing proteins. Another com-
prehensive chapter by David Vaux on this subject focuses on
the individual members of this family. This section further
highlights the domain structures and organisation of this
family, as well as their pathological roles as determined in
knockout mice or mutations in humans. The IAP genes have
been implicated in cancer and are ampliﬁed, translocated
or deleted in different malignancies. The structural basis of
the interaction between BIR-containing proteins and BCL2
family members is discussed in the following chapters,
authored by Hinds et al. These structural studies have led
to the development of several peptide mimetic drugs that are
in clinical trials at present. Another chapter is dedicated
to a more detailed analysis of structural features of protein
interactions in cell-death regulation (by Wu and Lo). This
chapter is very well organised and informative to the
non-experts.
Dead Corpses and Scavengers
Once cell death has occurred, the remains of the cell are often
engulfed by specialised cells. Alterations of this process can
lead to pathological states. This topic is extensively reviewed
by Nagata and colleagues who introduced us ﬁrst to the
‘ﬁnd-me’signalsthatdyingcellssecretetoattractprofessional
phagocytes. On binding to these signals, phagocytes upregu-
late the expression of speciﬁc genes involved in phago-
cytosis,suchasMFG-E8,abridging moleculethatrecognises
phosphatidyl serine (an ‘eat-me’ signal) on the apoptotic cell
and integrins on the phagocyte. An interesting comparison is
made between engulfment genes in C. elegans and mamma-
lian cells as the worm uses neighbouring sister cells, whereas
mammals use specialised professional phagocytes.
Self-Digestion: to Die or to Live?
Self-digestion can be achieved not only through induction of
apoptosisbutalsothroughadifferentintracellulardegradation
pathway known as autophagy. This chapter is timely due to a
recent explosion in interest and published reports on auto-
phagy. Autophagy has a Janus-type function in development,
tissue homeostasis and cancer, as it can serve as either
a pro- or anti-cell death mechanism. Two very chapters
expand on this subject, the ﬁrst authored by Colombo/Simon,
who provide a detailed outline of the molecular mechanisms
of autophagy and examine its role in a number of patho-
logies, including neurodegenerative disease, cardiac
disease, cancer, infection and inﬂammation. Interestingly,
they conclude with a discussion on how autophagy interplays
with cell death to spare cells from death or actually promote
apoptosis. The subject of the following chapter written by two
leading researchers in the ﬁeld, Eric Baehrecke and Jahda
Hill, introduces the genetics of autophagy. This chapter is well
written and understandable to the non-expert. Very helpful
insights are also given into the role of autophagy in disease
pathogenesis. For instance, the authors discuss a number of
studies suggesting that autophagy can compensate for
proteasome impairment and degrade intracellular aggregates
inmodelsofneurodegeneration.Inthisregard,autophagyhas
an anti-ageing effect in worms and ﬂies potentially through its
capacity to degrade intracellular, toxic aggregates. Lipton and
colleagues extensively discuss the available literature on the
effect of ROS and NO on protein misfolding and synaptic
damage. The exciting possibility that S-nitrosylation of
the ubiquitin ligase parkin and protein disulphide isomerase
can contribute to neurodegeneration is presented. The
authors also discuss the potential use of drugs that protect
neurons from oxidative stress in treating neurodegenerative
conditions.
Immune System, Pathogens and Cell Death
Alterations of programmed cell death have implications for
immunity and inﬂammatory diseases, as discussed in the
chapterbyLeBlancandSaleh.Theintroductiontothischapter
is very useful and sums up the history of immunity/inﬂamma-
tion research, by highlighting all the key ﬁndings in the last
half-century or so. Given the intricacy of the pathogen
recognition machinery, the authors have tried to summarise
and critically discuss the currently available literature. To this
end, they have chosen an evolutionary angle, supported by
helpfulcartoons,whichguidesthereaderthroughthedifferent
mechanisms regulating the response to pathogens from
insects to mammals. Finally, chapters on the involvement of
caspasesin inﬂammatorydisorders, andoncaspasesand the
immune response are well written, comprehensive and very
informative. This is deﬁnitely one of the better chapters.
Cell death has a major role in developing the immune
system and in modulating its response to pathogens. A well-
written chapter by Georg Haeker is dedicated to microbial
infections and their ability to inﬂuence cell death. This chapter
extensively reviews the mechanisms by which viruses,
intracellular/extracellular bacteria and parasites interact with
intracellular cell death pathways.
A further chapter focuses on immunity and cell killing.
This is the result of a combined effort by Nigel Waterhouse’s
group and Joseph Trapani, two leading experts in the ﬁeld
of granzymes. Importantly, the authors stress up front that
lysis-mediated cell death after formation of the synapse has
notbeenformallydemonstratedinvivo,andthatinsteadforms
of non-lytic cell death are more plausible. Furthermore, the
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escape the toxic effects of the perforin/granzyme system they
actually enable.
Too Much or Too Little (Death) is Equally Bad for You
The book then takes a turn and switches to alterations of
the apoptosis machinery in disease, a chapter authored by
Vince and Silke. Using two clear illustrations, they review
the components of the intrinsic and extrinsic pathways of
cell death, which are nicely illustrated in two ﬁgures. The
remainderofthearticleisdevotedtoadiscussionoftheroleof
apoptotic genes in human disease. Discussion of mutations in
patients is particularly informative. This is a very appealing
and generally well-constructed chapter.
A number of hereditary disorders are characterised by
alterations of the cell death machinery, as Su and Lenardo
nicelyillustrate.Inparticular,therolesofDRsandtheirligands
in autoimmune diseases are detailed with speciﬁc emphasis
on Fas, a major mediator of extrinsic apoptosis in lympho-
cytes. Selective ablation of the Fas/FasL gene or loss of
Fas signalling in dendritic, B or T cells has established that in
any of these cell subsets, Fas defects promote disease
by perturbing the normal cellular control mechanisms. The
human genetic autoimmune lymphoproliferative syndrome is
indeed due to defects in apoptosis. This chapter provides a
useful insight into how mutations in the components of the
apoptotic pathway can induce autoimmunity and unbalanced
lymphocyte homeostasis in humans.
What about cell death and cancer? A book on apoptosis
would not be complete without a chapter on the tumour
suppressor p53. This responsibility fell on Wolyniec et al.A s
beﬁtting its status as the most studied tumour suppressor, the
authors concentrate on p53 function in cancer, as opposed to
development or other pathologies. They then outline how
these stresses activate and regulate p53 and how p53 signals
apoptosis. After a (too brief from the point of view of those of
who study p63/p73) section on the other p53 family members,
the authors delineate how and what we have learned about
p53 function and regulation, which is now being translated for
therapy, with a number of small molecules and peptide-
derived candidates being developed as drugs.
When Corpses are Useful
Sometimes the presence of a ‘dead cell’ has a key
physiological role. This is the case of corniﬁcation of the skin,
a process discussed and reviewed by Candi et al. Corniﬁca-
tion of the skin is a highly regulated temporal and spatial
process of terminal differentiation of keratinocytes in which
theresultantdeadcellsformabarrierintheuppermostlayerof
the skin. The authors provide a thorough description of
the various classes of proteins and their enzymology as it
relates to corniﬁcation and the detailed coordination of their
interactions. In conclusion, a very informative comparison
of the similarities and differences in cell death in keratino-
cyte apoptosis in the skin basal layer, and the keratinocyte
terminal differentiation that constitutes corniﬁcation, is
elucidated.
And to Finishy
Fittingly, the last chapter in this textbook is entitled ‘Drug
Discovery in Apoptosis’, by O’Brien and Dixit. The authors
directly address the dichotomy between the beneﬁts and
harms of death effector molecules, speciﬁcally caspases,
in inﬂammatory diseases, infection, neurodegenerative
diseases and cancer. What is necessary is to realise that for
some pathologies, the clinician wishes to promote cell death,
whereas for others, prevention of cell death is of therapeutic
value. Focusing on caspase active site inhibitors, the authors
take us on an informative if more than sobering journey
through candidate drug discovery and clinical development.
Not all is doom and gloom as we are shown that alternative
approaches to caspase inhibition, based on allosteric
inhibition, may be more fruitful. Gratifyingly, at least in this
reviewer’s opinion, the authors discuss non-caspase targets
for drug discovery, such as pro-survival Bcl-2 family inhibitors
(but why not pro-apoptotic family member agonists?), IAP
inhibitors and SMAC-mimetics. With the number of possible
targets,greatermodiﬁcations, andexperienceofpastfailures,
there is hope that the mechanistic knowledge gained in the
past two decades of cell death research will soon translate to
success in the clinic for a wide range of diseases.
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